CVS241129C66000
- 0.01
- 0.000.00%
CVS Health Newsroom
CVS Health Shares Are Trading Higher After Cowen Maintained Its Buy Rating and Raised Its Price Target From $73 to $80. Piper Sandler Also Maintained Its Overweight Rating, but Lowered Its Price Target From $72 to $64.
CVS Health Is Maintained at Overweight by Piper Sandler
Piper Sandler Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $64
Piper Sandler Sticks to Their Buy Rating for CVS Health (CVS)
TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $80
CVS Health's Strategic Turnaround: Poised for Growth in Medicare Advantage and Market Share Gains by 2025
Express News | CVS Health Corp : Piper Sandler Cuts Target Price to $64 From $72
Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A 'Primetime' Year For AI
Pension Doubles Its Palantir Stake and Buys Up Intel and CVS. -- Barron's
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Investors Eye New PMI, Consumer Sentiment Data: Catalysts
Why Nvidia's Earnings Weren't All That Great for Stocks
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
Optimism Over Global Healthcare Sector Rises: Jefferies
(CVS) - Analyzing CVS Health's Short Interest
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
CVS Health's (NYSE:CVS) Earnings Trajectory Could Turn Positive as the Stock Lifts 4.7% This Past Week
Trump chooses Dr. Oz as the head of federal medical insurance, UnitedHealth (UNH.US) and other health insurance companies may emerge as winners.
Elected President Trump has chosen television personality Dr. Mehmet Oz to serve as the director of the usa Centers for Medicare and Medicaid Services (CMS).
CVS Health Analyst Ratings
Reported November 19, 2024 "CVS, Cigna, UnitedHealth Sue To Nix FTC Case On Insulin Cost" - Bloomberg Law